What is Peer Review of Medical Research Papers?
The aim of scientific research is to improve medical knowledge and find better ways to treat disease. As part of this process, publication in the medical journals enables the wider scientific community to share developments, and to test findings and take them further. Peer review is…
Pyriproxyfen Suspected of Causing Microcephaly in Brazil
A report published by Médicos de Pueblos Fumigados (Physicians in the Crop-Sprayed Villages) of Argentina on February 3, 2016 discounts the theory that the growth in the number of cases of babies born with microcephaly in Brazil during the past year are due to the Zika virus transmitted…
GSK Business Strategy Based on Selling Lots of Vaccines
In its latest effort to increase its sales volume for vaccines and other pharmaceutical products, GlaxoSmithKline (GSK) of Great Britain has officially launched GSKDirect, described as a new “e-commerce platform that simplifies the way customers order vaccines and pharmaceutical…
U.S. Vaccine Market Forecast at $17.4 Billion by 2018
The value of the market for vaccines in the United States will reach $17.4 billion in 2018, according to a study published by Transparency Market Research of Albany, NY. If accurate, the projection would represent a compound annual growth rate (CAGR) of 5.3% during 2012-2018. TMR estimated the US vaccine market at $12.8 billion in 2012. TMR attributes its optimistic forecast to…
Doctors Are No Experts on Vaccines
There is a common belief that doctors are “experts” on vaccines and vaccination. Almost nothing could be further from the truth. The average medical doctor, for example, may not know the names of the ingredients in vaccines, or what they are and how they interact with each other. The average doctor giving people vaccines may not know how vaccines affect the immune system…
Nominee for FDA Commissioner Has Pharma Industry Ties
If confirmed by Congress, the next commissioner of the U.S. Food and Drug Administration (FDA) will be Robert M. Califf, MD. Dr. Califf is currently the FDA’s deputy commissioner for Medical Products and Tobacco—a position to which he was appointed on January 26, 2015, just two months prior to the end of former FDA commissioner Margaret Hamburg’s six-year term.
